TCF7 and breast carcinoma: Combined analysis demonstrated that breast cancer patients with CD8 (low) and CD163 (high) as well as CD8 + TCF1 + (low) and CD163 (high) levels were associated with worse DFS (p < 0.0001 and p = 0.00023, respectively; Fig. 5a, b).